Rocket Pharmaceuticals, Inc.
Status: Publicly traded
Direct answer
Rocket Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker RCKT.
Rocket Pharmaceuticals, Inc., operating alongside its affiliates, is an innovative biotechnology enterprise dedicated to pioneering gene therapies for rare and severely debilitating diseases. The company's active clinical pipeline features multiple promising programs. It is currently progressing three ex vivo lentiviral vector therapies aimed at specific genetic conditions: Fanconi anemia, characterized by a bone...
Can you invest in Rocket Pharmaceuticals, Inc.?
Yes. Rocket Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker RCKT.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Rocket Pharmaceuticals, Inc.
Detailed equity research is provided by MarketSnap.